NASDAQ:PRPO Precipio (PRPO) Stock Price, News & Analysis $17.74 +1.64 (+10.19%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$18.10 +0.36 (+2.03%) As of 09/5/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Precipio Stock (NASDAQ:PRPO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Precipio alerts:Sign Up Key Stats Today's Range$16.10▼$17.7850-Day Range$10.92▼$17.7452-Week Range$3.90▼$17.78Volume33,225 shsAverage Volume10,389 shsMarket Capitalization$28.74 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. Read More Precipio Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScorePRPO MarketRank™: Precipio scored higher than 19% of companies evaluated by MarketBeat, and ranked 859th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Precipio. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Precipio is -14.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Precipio is -14.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPrecipio has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Precipio's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.53% of the float of Precipio has been sold short.Short Interest Ratio / Days to CoverPrecipio has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Precipio has recently decreased by 19.78%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrecipio does not currently pay a dividend.Dividend GrowthPrecipio does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.53% of the float of Precipio has been sold short.Short Interest Ratio / Days to CoverPrecipio has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Precipio has recently decreased by 19.78%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News Sentiment1.00 News SentimentPrecipio has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Precipio this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for PRPO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Precipio insiders have not sold or bought any company stock.Percentage Held by Insiders16.90% of the stock of Precipio is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.45% of the stock of Precipio is held by institutions.Read more about Precipio's insider trading history. Receive PRPO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRPO Stock News HeadlinesPrecipio Ends ATM Agreement with Alliance GlobalSeptember 4 at 2:05 AM | msn.comPrecipio Terminates Its ATMSeptember 2, 2025 | markets.businessinsider.comTrump’s national nightmare is hereWashington just added $1 trillion to the national debt in less than two months — an astonishing pace of spending that rivals wartime levels. But according to two veteran analysts, this isn’t recklessness. It’s a deliberate mobilization for what could be America’s most consequential arms race yet. The warning signs are everywhere: ballooning deficits, record shortfalls, and strategic moves to secure resources and manufacturing. If you’ve got money in the market or savings in the bank, understanding what’s happening behind the scenes may be critical. | Porter & Company (Ad)Precipio, Inc. Terminates ATM Agreement with Alliance Global Partners to Strengthen Financial PositionSeptember 2, 2025 | quiverquant.comQPrecipio, Inc. (NASDAQ:PRPO) Q2 2025 Earnings Call TranscriptAugust 16, 2025 | msn.comPrecipio Reports Improved Earnings Amidst Ongoing ChallengesAugust 16, 2025 | msn.comPrecipio, Inc. (PRPO) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comPrecipio, Inc.: Precipio Announces its Q2-2025 Financial ResultsAugust 14, 2025 | finanznachrichten.deSee More Headlines PRPO Stock Analysis - Frequently Asked Questions How have PRPO shares performed this year? Precipio's stock was trading at $5.54 at the beginning of 2025. Since then, PRPO shares have increased by 220.2% and is now trading at $17.74. How were Precipio's earnings last quarter? Precipio, Inc. (NASDAQ:PRPO) issued its earnings results on Wednesday, August, 13th. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter. The biotechnology company had revenue of $5.65 million for the quarter. Precipio had a negative trailing twelve-month return on equity of 15.00% and a negative net margin of 8.48%. Read the conference call transcript. When did Precipio's stock split? Shares of Precipio reverse split before market open on Friday, September 22nd 2023.The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Precipio's major shareholders? Top institutional shareholders of Precipio include AMH Equity Ltd (1.85%). Insiders that own company stock include Richard A Sandberg, Ilan Danieli and Ahmed Zaki Sabet. View institutional ownership trends. How do I buy shares of Precipio? Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Precipio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include NVIDIA (NVDA), Meta Platforms (META), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Broadcom (AVGO), CrowdStrike (CRWD) and GE Aerospace (GE). Company Calendar Last Earnings8/13/2025Today9/06/2025Next Earnings (Estimated)11/17/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:PRPO CIK1043961 Webwww.precipiodx.com Phone(203) 787-7888Fax402-452-5401Employees60Year FoundedN/AProfitability EPS (Trailing Twelve Months)($1.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$4.29 million Net Margins-8.48% Pretax Margin-8.48% Return on Equity-15.00% Return on Assets-10.21% Debt Debt-to-Equity Ratio0.05 Current Ratio0.93 Quick Ratio0.69 Sales & Book Value Annual Sales$21.24 million Price / Sales1.35 Cash FlowN/A Price / Cash FlowN/A Book Value$8.16 per share Price / Book2.17Miscellaneous Outstanding Shares1,620,000Free Float1,346,000Market Cap$28.74 million OptionableNo Data Beta1.09 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:PRPO) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.